Financial report interval: 2025.03.30 - 2025.06.30
Overview: AB&B BIO-TECH-B(02627) the Revenue is 77.39 M (+979.5%);the EBIT is -33.01 M (+66.06%);the EPS is -0.104 (+62.33%).